# A Multiple Ascending Dose Study of Safety and Pharmacokinetics of NP10679 in Normal Healthy Volunteers

> **NCT04007263** · PHASE1 · COMPLETED · sponsor: **Neurop Inc.** · enrollment: 24 (actual)

## Conditions studied

- Stroke, Ischemic
- Pain, Postoperative
- Substance Abuse
- Subarachnoid Hemorrhage

## Interventions

- **DRUG:** Placebo
- **DRUG:** NP10679

## Key facts

- **NCT ID:** NCT04007263
- **Lead sponsor:** Neurop Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-04
- **Primary completion:** 2019-08-30
- **Final completion:** 2019-10-10
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2019-11-04

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04007263

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04007263, "A Multiple Ascending Dose Study of Safety and Pharmacokinetics of NP10679 in Normal Healthy Volunteers". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04007263. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*